Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Abvida-M 50/1000 Tablet

Prescription Icon
Prescription Required

Marketer

Abbott

Salt Composition

Metformin (1000mg) + Vildagliptin (50mg)

Overview Abvida-M 50/1000 Tablet

Eazy Glide SR, a dual-action tablet known as Abvida-M 50/1000, effectively manages elevated blood glucose in individuals with type 2 diabetes. This dual therapy helps mitigate severe diabetic complications, such as renal impairment and vision loss, and may lessen the risk of cardiovascular events. Abvida-M 50/1000 Eazy Glide SR may be used independently or in conjunction with other antidiabetic agents. Optimal results are achieved when combined with a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood glucose readings, and other medications. Consuming it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. It regulates blood sugar, preventing future serious complications. Adherence to the prescribed diet and exercise plan is crucial for successful diabetes management; lifestyle significantly influences disease control. Common side effects include nausea, vomiting, diarrhea, abdominal discomfort, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia, especially when combined with insulin or sulfonylureas, is a potential adverse effect requiring prompt recognition and management. This medication is not universally suitable. Prior to commencing treatment, inform your physician of any pre-existing kidney, liver, or cardiac conditions, pancreatic disorders, or excessive alcohol consumption. Pregnant or lactating women should consult their doctor. Potential drug interactions exist; disclose all medications to ensure safety. Alcohol should be minimized due to its hypoglycemic effects. Kidney function and blood glucose will be monitored regularly throughout treatment.

Uses of Abvida-M 50/1000 Tablet

Managing type 2 diabetes

Major Benefits of Abvida-M 50/1000 Tablet :

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Abvida-M 50/1000 Eazy Glide Tablet SR should be administered with a meal.

Common Side effects of Abvida-M 50/1000 Tablet :

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Abvida-M 50/1000 Tablet :

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Abvida-M 50/1000 Eazy Glide Tablet SR should be administered with a meal.

How Abvida-M 50/1000 Tablet works:

Eazy Glide SR tablets, branded Abvida-M 50/1000, contain a dual-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Abvida-M 50/1000 Eazy Glide Tablet SR is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Abvida-M 50/1000 Eazy Glide Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescription. Consult your physician for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Abvida-M 50/1000 Eazy Glide tablet is likely not safe for use while breastfeeding. Available human data indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Abvida-M 50/1000 Eazy Glide SR tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Abvida-M 50/1000 Eazy Glide Tablet SR due to potential safety concerns. Medical advice is recommended.

What if you forget to take Abvida-M 50/1000 Tablet :

Should you forget a dose of Abvida-M 50/1000 Eazy Glide Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Abvida-M 50/1000 Tablet

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Abvida-M 50/1000 Tablet

Abvida-M 50/1000 Eazy Glide Tablet SR typically does not induce hypoglycemia (low blood glucose) by itself. However, insufficient caloric intake during treatment may lead to low blood sugar. Manifestations of hypoglycemia encompass nausea, headache, irritability, hunger, diaphoresis, vertigo, tachycardia, and feelings of anxiety or tremor. These symptoms are more prominent if meals are skipped or delayed, alcohol is consumed, strenuous exercise is undertaken, or concomitant antidiabetic medications are used. Therefore, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is advisable.
Nausea and vomiting are potential side effects of Abvida-M 50/1000 Eazy Glide Tablet SR. If vomiting occurs, replenish fluids by sipping small amounts of water or other beverages frequently. Consult your physician if vomiting continues or if you experience dehydration symptoms such as dark, concentrated urine, infrequent urination, or other signs of dehydration. Always seek medical advice before taking any additional medications.
Patients with hypersensitivity to Abvida-M 50/1000 Eazy Glide Tablet SR constituents or inactive ingredients should not use this medication. Furthermore, its administration is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store the medication in its original, tightly sealed container or packaging, following all storage instructions provided on the label. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Abvida-M 50/1000 Eazy Glide SR tablets contain metformin and vildagliptin, both medications used to manage diabetes. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose uptake, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts pancreatic insulin secretion. This dual therapy is unsuitable for individuals under 18.
Abvida-M 50/1000 Eazy Glide Tablet SR may cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is a rare complication of metformin use, prompting its avoidance in individuals with impaired kidney function, advanced age, or significant alcohol consumption. Symptoms can include muscular discomfort or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal pain, and bradycardia. Should these symptoms arise, discontinue Abvida-M 50/1000 Eazy Glide Tablet SR and seek immediate medical attention.
Prolonged use of Abvida-M 50/1000 Eazy Glide Tablet SR can lead to Vitamin B12 deficiency due to impaired Vitamin B12 absorption in the gastrointestinal tract. This deficiency, if left unmanaged, may result in anemia and neurological complications.
Using Abvida-M 50/1000 Eazy Glide Tablet SR as directed by your physician for the specified period is considered safe. Nevertheless, even with correct dosage, side effects such as nausea, diarrhea, vomiting, indigestion, headache, nasal stuffiness, throat irritation, respiratory infection, and low blood sugar (hypoglycemia, particularly when used with insulin or sulfonylureas) may occur. Report any ongoing issues to your doctor while using this medication.
Abvida-M 50/1000 Tablet
353